Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

Lekuona I, Anguita M, Zamorano JL, Rodríguez JM, Barja de Soroa P, Pérez-Alcántara F.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):398-406. doi: 10.1016/j.rec.2018.03.024. Epub 2018 Jul 7. English, Spanish.

PMID:
31007166
2.

Estimate of the cost of multiple sclerosis in Spain by literature review.

Fernández O, Calleja-Hernández MA, Meca-Lallana J, Oreja-Guevara C, Polanco A, Pérez-Alcántara F.

Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):321-333. doi: 10.1080/14737167.2017.1358617. Epub 2017 Jul 28. Review.

PMID:
28726515
3.

Comparative Efficacy And Costs Of Treatment Sequences In Metastatic Castration Resistant Prostate Cancer.

Pérez-Alcántara F, Martínez Llinàs D, Maroto JP, Gallardo E, Subirà R, Rubio M.

Value Health. 2015 Nov;18(7):A458. doi: 10.1016/j.jval.2015.09.1175. Epub 2015 Oct 20. No abstract available.

4.

Are Spanish Regions Implementing The National Therapeutic Positioning Report (Tpr) Regarding New Oral Anticoagulants (Noac) In The Same Way? A Case Of Regional Variability In Drug Access.

Rodriguez Barrios JM, Pérez-Alcántara F, Gonzalez-Juantey JR, Avendaño C, Suarez C, López-Bastida J, Barja de Soroa P.

Value Health. 2015 Nov;18(7):A404. doi: 10.1016/j.jval.2015.09.943. Epub 2015 Oct 20. No abstract available.

5.

Is Edoxaban Cost-Effective For Non-Valvular Atrial Fibrillation Patients Treated With Vitamin K Antagonists In Spain?

Lekuona I, Anguita M, Zamorano JL, Barja P, Rodríguez JM, Pérez-Alcántara F.

Value Health. 2015 Nov;18(7):A392. doi: 10.1016/j.jval.2015.09.873. Epub 2015 Oct 20. No abstract available.

6.

Is Edoxaban A Cost-Effective Alternative To Venous Thromboembolim Patients Treated With Vitamin K Antagonists In Spain?

Jiménez D, Suárez C, Barja P, Rodríguez JM, Pérez-Alcántara F.

Value Health. 2015 Nov;18(7):A390-1. doi: 10.1016/j.jval.2015.09.867. Epub 2015 Oct 20. No abstract available.

7.

Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study.

Carrato A, García P, López R, Macarulla T, Rivera F, Sastre J, Gostkorzewicz J, Benedit P, Pérez-Alcántara F.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):579-89. doi: 10.1586/14737167.2015.1047349. Epub 2015 May 19.

PMID:
25991037
8.

[Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain].

Donnay Candil S, Balsa Barro JA, Álvarez Hernández J, Crespo Palomo C, Pérez-Alcántara F, Polanco Sánchez C.

Endocrinol Nutr. 2015 Aug-Sep;62(7):322-30. doi: 10.1016/j.endonu.2015.03.007. Epub 2015 May 11. Spanish.

PMID:
25977144
9.

Cost-Effectiveness Analysis of Allergen Immunotherapy in Patients With Grass Pollen-Induced Allergic Rhinitis in Spain.

Valero A, Westerhout KY, van de Wetering G, Pérez-Alcántara F, Azpeitia A, Najib M.

Value Health. 2014 Nov;17(7):A598. doi: 10.1016/j.jval.2014.08.2067. Epub 2014 Oct 26. No abstract available.

10.

Burden of illness attributable to subclinical hypothyroidism in the Spanish population.

Donnay S, Balsa JA, Álvarez J, Crespo C, Pérez-Alcántara F, Polanco C.

Rev Clin Esp (Barc). 2013 Nov;213(8):363-9. doi: 10.1016/j.rce.2013.04.009. Epub 2013 Jun 15. English, Spanish.

PMID:
23773909
11.

Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain.

Alba E, Ciruelos E, López R, López-Vega JM, Lluch A, Martín M, Muñoz M, Sánchez-Rovira P, Seguí MÁ, Liria MR, Pérez-Alcántara F.

Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):381-91. doi: 10.1586/erp.13.18. Epub 2013 Mar 28.

PMID:
23534988
12.

The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications.

Rodríguez Barrios JM, Pérez Alcántara F, Crespo Palomo C, González García P, Antón De Las Heras E, Brosa Riestra M.

Eur J Health Econ. 2012 Dec;13(6):723-40. doi: 10.1007/s10198-011-0326-y. Epub 2011 Jun 10. Review.

PMID:
21660565

Supplemental Content

Loading ...
Support Center